NMUS Nemus Bioscience Panel Discussion at ROTH Conference

When:
March 17, 2019 – March 19, 2019 all-day
2019-03-17T00:00:00-04:00
2019-03-20T00:00:00-04:00

Nemus Bioscience, Inc. (OTCQB: $NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer Dr. Brian Murphy will participate in a panel discussion, “Cannabinoid Pharmaceuticals,” at the 31st Annual ROTH Conference being held on March 17-19, 2019, at The Ritz Carlton, Laguna Niguel in Orange County, CA.

 

Nemus Bioscience to Present at 31st Annual ROTH Conference

 

Discussion on the $NMUS forum.

Leave a Reply